TrialKidney3602026

Dapagliflozin Mitigates Medullary Hypoxia in CKD Patients: Analysis of Blood Oxygenation Level-Dependent Magnetic Resonance Imaging Renal Data from the Randomized Glucose Transport and Renal Protection in CKD Trial.

Elisa Russo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.